Literature DB >> 3411968

Ornithine decarboxylase levels in the rectal mucosa of patients with colonic neoplasia.

H B Koo1, E R Sigurdson, J M Daly, M Berenson, S Groshen, J J Decosse.   

Abstract

Ornithine decarboxylase (ODC) activity in biopsy specimens of normal-appearing rectal mucosa was measured in 15 control patients, 5 patients with colon adenomas, and 11 patients with colon cancer. While women had significantly higher ODC activity than men, ODC activity was increased regardless of gender in the rectal mucosal biopsies of patients with benign or malignant colonic neoplasia compared with those of controls. The positive predictive value of ODC activity for remote colonic neoplasia was 61% for women and 91% for men. The results provide a rationale for long-term studies of ODC activity in rectal mucosa as a biological marker of high risk for large bowel neoplasia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411968     DOI: 10.1002/jso.2930380407

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

Review 1.  A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.

Authors:  J T Cross; E M Poole; C M Ulrich
Journal:  Pharmacogenomics J       Date:  2008-01-15       Impact factor: 3.550

2.  Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.

Authors:  Francis M Giardiello; Robert A Casero; Stanley R Hamilton; Linda M Hylind; Jill D Trimbath; Deborah E Geiman; Katharine R Judge; Walter Hubbard; G Johan A Offerhaus; Vincent W Yang
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.